SCHEMBL28956762

SCHEMBL28956762

Nc1nc(Nc2cccc(S(N)(=O)=O)c2)ncc1-c1ccc(CCCF)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 9/20 0.49
▸ CDK1 P06493 9/20 0.49
▸ CDK5 Q00535 5/20 0.49
▸ CCNT1 O60563 5/20 0.49
▸ CCNB1 P14635 5/20 0.49
▸ CDK9 P50750 5/20 0.49
▸ CCNE1 P24864 5/20 0.49
▸ CDK5R1 Q15078 3/20 0.49
▸ CCNA2 P20248 3/20 0.49
▸ CCND3 P30281 1/20 0.49
▸ FLT3 P36888 1/20 0.49
▸ CDK6 Q00534 1/20 0.49
▸ NTRK1 P04629 3/20 0.47
▸ CCNE2 O96020 4/20 0.46
▸ AURKA O14965 3/20 0.46
▸ DCLK1 O15075 3/20 0.46
▸ AURKB Q96GD4 3/20 0.46
▸ SYK P43405 3/20 0.46
▸ CCNB2 O95067 3/20 0.46
▸ CCNB3 Q8WWL7 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28247410 0.91 CDK1 (0.51) CDK2CDK1CDK5CCNT1CCNB1
SCHEMBL28246722 0.90 CDK1 (0.50) CDK2CDK1CDK5CCNT1CCNB1
SCHEMBL28059063 0.88 CDK1 (0.54) CDK2CDK1CDK5CCNT1CCNB1
SCHEMBL28059048 0.83 CDK1 (0.50) CDK2CDK1CDK5CCNT1CCNB1
Hydrochloric Acid SCHEMBL28247591 0.83 CDK1 (0.49) CDK2CDK1CDK5CCNT1CCNB1
SCHEMBL3996202 0.81 JAK3 (0.60) CDK2CDK1CDK5CCNT1CCNB1
SCHEMBL28246650 0.80 CDK2 (0.47) CDK2CDK1CDK5CCNT1CCNB1
SCHEMBL28865244 0.80 CDK1 (0.47) CDK2CDK1CDK5CCNT1CCNB1
SCHEMBL28247414 0.79 CDK1 (0.46) CDK2CDK1CDK5CCNT1CCNB1
SCHEMBL28247405 0.79 CDK1 (0.51) CDK2CDK1CDK5CCNT1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105348203-B Inhibit the composition and method of JAK approach 里格尔药品股份有限公司 2018-09-18 — — CN disclosed
Send feedback